UnitedHealth Group shares rose over 5% following Bank of America's upgrade to 'Buy' due to improving medical cost trends and a favorable risk-reward outlook ahead of earnings. The bank increased its price target to $450 and raised earnings estimates for 2026 and 2027. Analysts highlighted positive near-term data in the managed care sector, suggesting UnitedHealth could lead a broader recovery in Medicare Advantage stocks. Despite some risks like Medicare star ratings and 2028 rate proposals, the outlook remains constructive if cost trends and margins improve.
Piper Sandler raised its price target for UnitedHealth Group to $475, suggesting a 13.3% upside from its current price of $419.23. The company, the largest U.S. health insurer, has consistently beaten earnings estimates, with its latest EPS of $7.23 ...
The SCHD ETF has returned just under 2% in the past month, outperforming the S&P 500 ETF (SPY) by nearly 1%. Year-to-date, about 30 SCHD holdings have more than doubled the returns of SPY, which has returned 9.8%. Additionally, 31 SCHD holdings are t...
Elevance Health and UnitedHealth Group, two of the largest U.S. health insurers, are set to report their second-quarter earnings this week. Investors and analysts are watching closely to see if these companies have maintained control over rising medi...
